KIF22 promotes bladder cancer progression by activating the expression of CDCA3

Kai Li, Song Li, Shuai Tang, Minghao Zhang, Zhen Ma, Qi Wang, Fangmin Chen

Open source

DOI
10.3892/ijmm.2021.5044
Published
2021-10-07
Container
International Journal of Molecular Medicine
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ijmm.2021.5044,
  title = {KIF22 promotes bladder cancer progression by activating the expression of CDCA3},
  author = {Kai Li and Song Li and Shuai Tang and Minghao Zhang and Zhen Ma and Qi Wang and Fangmin Chen},
  year = {2021},
  journal = {International Journal of Molecular Medicine},
  doi = {10.3892/ijmm.2021.5044},
  url = {https://doi.org/10.3892/ijmm.2021.5044}
}

RIS

TY  - JOUR
TI  - KIF22 promotes bladder cancer progression by activating the expression of CDCA3
AU  - Kai Li
AU  - Song Li
AU  - Shuai Tang
AU  - Minghao Zhang
AU  - Zhen Ma
AU  - Qi Wang
AU  - Fangmin Chen
PY  - 2021
JO  - International Journal of Molecular Medicine
DO  - 10.3892/ijmm.2021.5044
UR  - https://doi.org/10.3892/ijmm.2021.5044
ER  - 

APA

Li, K., Li, S., Tang, S., Zhang, M., Ma, Z., Wang, Q., & Chen, F. (2021). KIF22 promotes bladder cancer progression by activating the expression of CDCA3. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2021.5044

Source records